Advancing Precision Medicine through Innovation.

Genovo delivers next-generation diagnostic solutions, from BCR-ABL1 quantification to advanced miRNA and immune repertoire sequencing libraries.

Products

Our Core Solutions

Cutting-edge technologies designed for clinical reliability and research discovery.

Absolute quantification of BCR-ABL1 fusion transcripts for CML monitoring with WHO scale traceability.

Unbiased immune repertoire sequencing for characterizing adaptive immune responses.

End-to-end exosome isolation, quantification, and biomarker discovery for liquid biopsy research.

Magnetic particle-based nucleic acid isolation from plasma and serum with superior efficiency and purity in just ~1.5 hours.